Aditya Birla Sun Life Pharma & Healthcare Fund - Dividend - Direct Plan

  • Previous Nav

  • Net Change on 14-11-2019

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Dividend | Direct Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

Investment objective of the scheme is to provide long term capital appreciation by investing in equity & equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes objectives will be achieved.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
S&P BSE Health Care - TRI 6.62 3.29 -9.78 -5.13 -2.34 11.40

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Nippon India Pharma Fund - Direct Plan Dividend Plan Jan 01, 2013 Unrated -4.48 1.72 3.97 1.36 2,429.66
UTI Healthcare Fund -Direct Plan - Income Option Jan 01, 2013 Unrated -4.97 -2.78 -0.25 1.76 392.78

Fund Holdings as on 31-October-2019

  • Sun Pharmaceutical Industries Limited

  • Clearing Corporation of India Limited

  • Cipla Limited

  • Lupin Limited

  • Alkem Laboratories Limited

  • Divi's Laboratories Limited

  • Atul Limited

  • Apollo Hospitals Enterprise Limited

  • Torrent Pharmaceuticals Limited

  • Dr. Reddy's Laboratories Limited

  • Aurobindo Pharma Limited

  • Pfizer Limited

  • METROPOLIS HEALTHCARE LIMITED

  • Zydus Wellness Limited

  • Sanofi India Limited

  • Natco Pharma Limited

  • Strides Pharma Science Limited

  • ALEMBIC PHARMACEUTICALS LIMITED

  • Biocon Limited

  • Eris Lifesciences Limited

  • ICICI Lombard General Insurance Company Limited

  • Dishman Carbogen Amcis Limited

  • Aster DM Healthcare Limited

  • Avenue Therapeutics Inc

  • Net Receivables / (Payables)

View More
  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Chemicals

  • Miscellaneous

  • Consumer Food

  • Insurance

View More

About Aditya Birla Sun Life Pharma & Healthcare Fund

Scheme Analysis

Aditya Birla Sun Life Pharma & Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Aditya Birla Sun Life Mutual Fund. It was launched on 10-Jul-2019 and currently has an AUM of ₹170.53 crore. Aditya Birla Sun Life Pharma & Healthcare Fund is benchmarked against S&P BSE Health Care - TRI as primary index.

The NAV of Aditya Birla Sun Life Pharma & Healthcare Fund ended down ₹-0.03(-0.29%)yesterday to ₹10.3.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Limited, Clearing Corporation of India Limited and Cipla Limited

The Aditya Birla Sun Life Pharma & Healthcare Fund is managed by Dhaval Shah .

Fund House Contact

One India Bulls Centre , Tower 1, 17th Floor, Jupiter Mill Compound, 841, Senapati Bapat Marg, Elphinstone Road, Mumbai - 400 013

022-43568000
022-43568110/ 8111

Fund Manager

  • Cash

  • Equity

View More